Give an example of price discrimination or personalized pricing from your company or from your general experience. Explain the impacts on producers and consumers. Think about things like seller profitability, market share/market power, and be sure to think about the impact on consumer welfare/consumer surplus.
In: Economics
If you are to be acquired by another company, what will be the least preferred defense maneuver of your choice? Kindly explain the defense you will least likely use and elaborate further why such defense is your least among the choices.
In: Accounting
Explain in your own words why you need to turn the brightness of the lamp up when you use an x100 objective compared to an x10 objective
Describe in your own words what depth of field is
In: Biology
If you were the director of the Centers for Disease Control and Prevention (CDC), what measures would you implement to reduce the US vulnerability to pandemics in the future? Explain your answer; use evidence to support your answer.
In: Biology
Compare and contrast Gartner's Hype Cycle with the technology S-Curve, explain, from your own opinion:
- What are their similarities?
- How do they differ?
- Which one is better or more suitable for your use? Why?
In: Operations Management
Create a simple 0, 1 integer model for a situation or problem you face in your life. Is there an optimal solution for your problem? What type of model would you use to create an optimal solution? Explain.
In: Economics
In June 2008, the Journal of the American Academy of Dermatology reported on the use of an intermittent therapy for flare prevention and long-term disease control of eczema (red, inflamed, itchy skin). Eczema is a chronic skin disease that affects about 10% to 20% of infants and about 3% of adults and children in the United States. Researchers wanted to determine whether intermittent dosing with a specific topical inhibitor is effective in preventing eczema flare-ups in patients with stabilized eczema. Initially, 383 adults and children with moderate to severe eczema were treated with daily doses of the topical inhibitor. After 16 weeks, 197 were disease free and admitted into the maintenance phase of the study. These patients were randomized to a 3-times-weekly treatment with either the topical inhibitor or a placebo for 40 weeks. All tubes of ointments (topical inhibitor and placebo) were packaged in identical boxes and labeled “for investigational use only.” Then the packages were sealed with tamper-proof seals and shipped. Neither the researchers nor the patients knew who received the topical inhibitor or who received the placebo. During the maintenance phase researchers tracked the number of flare-free days for each patient.
Which of the following design features contributes to double
blinding?
A.Randomization of patients to one of two groups
B. Distinguishing the packaging for both treatments
C. The number of flare-free days for each patient
In: Statistics and Probability
Comparative balance sheets for 2021 and 2020, a statement of
income for 2021, and additional information from the accounting
records of Red, Inc., are provided below.
| RED, INC. Comparative Balance Sheets December 31, 2021 and 2020 ($ in millions) |
|||||||
| 2021 | 2020 | ||||||
| Assets | |||||||
| Cash | $ | 32 | $ | 128 | |||
| Accounts receivable | 149 | 140 | |||||
| Prepaid insurance | 8 | 4 | |||||
| Inventory | 301 | 183 | |||||
| Buildings and equipment | 416 | 358 | |||||
| Less: Accumulated depreciation | (127 | ) | (248 | ) | |||
| $ | 779 | $ | 565 | ||||
| Liabilities | |||||||
| Accounts payable | $ | 95 | $ | 116 | |||
| Accrued liabilities | 7 | 12 | |||||
| Notes payable | 58 | 0 | |||||
| Bonds payable | 170 | 0 | |||||
| Shareholders’ Equity | |||||||
| Common stock | 408 | 408 | |||||
| Retained earnings | 41 | 29 | |||||
| $ | 779 | $ | 565 | ||||
| RED, INC. Statement of Income For Year Ended December 31, 2021 |
||||||
| ($ in millions) | ||||||
| Revenues | ||||||
| Sales revenue | $ | 2,060 | ||||
| Expenses | ||||||
| Cost of goods sold | $ | 1,457 | ||||
| Depreciation expense | 41 | |||||
| Operating expenses | 492 | 1,990 | ||||
| Net income | $ | 70 | ||||
Additional information from the accounting
records:
Required:
Prepare the statement of cash flows of Red, Inc., using the direct
method to report operating activities. (Enter your answers
in millions (i.e., 10,000,000 should be entered as 10). Amounts to
be deducted should be indicated with a minus sign.)
In: Accounting
Comparative balance sheets for 2021 and 2020, a statement of
income for 2021, and additional information from the accounting
records of Red, Inc., are provided below.
| RED, INC. Comparative Balance Sheets December 31, 2021 and 2020 ($ in millions) |
|||||||
| 2021 | 2020 | ||||||
| Assets | |||||||
| Cash | $ | 35 | $ | 134 | |||
| Accounts receivable | 200 | 143 | |||||
| Prepaid insurance | 5 | 3 | |||||
| Inventory | 307 | 186 | |||||
| Buildings and equipment | 422 | 361 | |||||
| Less: Accumulated depreciation | (130 | ) | (251 | ) | |||
| $ | 839 | $ | 576 | ||||
| Liabilities | |||||||
| Accounts payable | $ | 98 | $ | 122 | |||
| Accrued liabilities | 4 | 9 | |||||
| Notes payable | 61 | 0 | |||||
| Bonds payable | 173 | 0 | |||||
| Shareholders’ Equity | |||||||
| Common stock | 411 | 411 | |||||
| Retained earnings | 92 | 34 | |||||
| $ | 839 | $ | 576 | ||||
| RED, INC. Statement of Income For Year Ended December 31, 2021 |
||||||
| ($ in millions) | ||||||
| Revenues | ||||||
| Sales revenue | $ | 2,110 | ||||
| Expenses | ||||||
| Cost of goods sold | $ | 1,424 | ||||
| Depreciation expense | 41 | |||||
| Operating expenses | 526 | 1,991 | ||||
| Net income | $ | 119 | ||||
Additional information from the accounting
records:
Required:
Prepare the statement of cash flows of Red, Inc., using the direct
method to report operating activities. (Enter your answers
in millions (i.e., 10,000,000 should be entered as 10). Amounts to
be deducted should be indicated with a minus
sign.)
In: Accounting
Comparative balance sheets for 2018 and 2017, a statement of
income for 2018, and additional information from the accounting
records of Red, Inc., are provided below.
| RED, INC. Comparative Balance Sheets December 31, 2018 and 2017 ($ in millions) |
|||||||
| 2018 | 2017 | ||||||
| Assets | |||||||
| Cash | $ | 44 | $ | 152 | |||
| Accounts receivable | 198 | 152 | |||||
| Prepaid insurance | 12 | 5 | |||||
| Inventory | 325 | 195 | |||||
| Buildings and equipment | 440 | 370 | |||||
| Less: Accumulated depreciation | (139 | ) | (260 | ) | |||
| $ | 880 | $ | 614 | ||||
| Liabilities | |||||||
| Accounts payable | $ | 107 | $ | 140 | |||
| Accrued expenses payable | 11 | 16 | |||||
| Notes payable | 70 | 0 | |||||
| Bonds payable | 181 | 0 | |||||
| Shareholders’ Equity | |||||||
| Common stock | 420 | 420 | |||||
| Retained earnings | 91 | 38 | |||||
| $ | 880 | $ | 614 | ||||
| RED, INC. Statement of Income For Year Ended December 31, 2018 |
||||||
| ($ in millions) | ||||||
| Revenues | ||||||
| Sales revenue | $ | 2,200 | ||||
| Expenses | ||||||
| Cost of goods sold | $ | 1,482 | ||||
| Depreciation expense | 50 | |||||
| Operating expenses | 545 | 2,077 | ||||
| Net income | $ | 123 | ||||
Additional information from the accounting
records:
Required:
Prepare the statement of cash flows of Red, Inc. using the indirect
method to report operating activities. (Amounts to be
deducted should be indicated with a minus sign. Enter your answers
in millions (i.e., 10,000,000 should be entered as
10).)
In: Accounting